These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 14712301

  • 1. Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma.
    Wu MH, Yokozeki H, Takagawa S, Yamamoto T, Satoh T, Kaneda Y, Katayama I, Nishioka K.
    Gene Ther; 2004 Jan; 11(2):170-80. PubMed ID: 14712301
    [Abstract] [Full Text] [Related]

  • 2. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T, Nishioka K.
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [Abstract] [Full Text] [Related]

  • 3. Effect of intramuscular injection of hepatocyte growth factor plasmid DNA with electroporation on bleomycin-induced lung fibrosis in rats.
    Long X, Xiong SD, Xiong WN, Xu YJ.
    Chin Med J (Engl); 2007 Aug 20; 120(16):1432-7. PubMed ID: 17825173
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
    Kohno S, Endo H, Hashimoto A, Hayashi I, Murakami Y, Kitasato H, Kojima F, Kawai S, Kondo H.
    Biomed Pharmacother; 2006 Jan 20; 60(1):18-25. PubMed ID: 16337105
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma.
    Iwasaki T, Imado T, Kitano S, Sano H.
    Arthritis Res Ther; 2006 Jan 20; 8(6):R161. PubMed ID: 17049072
    [Abstract] [Full Text] [Related]

  • 6. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
    J Cell Physiol; 2005 May 20; 203(2):447-56. PubMed ID: 15605379
    [Abstract] [Full Text] [Related]

  • 7. Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma.
    Nakamura-Wakatsuki T, Oyama N, Yamamoto T.
    Exp Dermatol; 2012 Mar 20; 21(3):189-94. PubMed ID: 22188586
    [Abstract] [Full Text] [Related]

  • 8. Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma.
    Yamamoto T, Takagawa S, Katayama I, Nishioka K.
    Clin Immunol; 1999 Jul 20; 92(1):6-13. PubMed ID: 10413648
    [Abstract] [Full Text] [Related]

  • 9. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice.
    Yang J, Dai C, Liu Y.
    Gene Ther; 2001 Oct 20; 8(19):1470-9. PubMed ID: 11593360
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.
    Arthritis Rheum; 2004 Jan 20; 50(1):216-26. PubMed ID: 14730619
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of TGF-beta1 in the sclerotic skin in bleomycin-'susceptible' mouse strains.
    Oi M, Yamamoto T, Nishioka K.
    J Med Dent Sci; 2004 Mar 20; 51(1):7-17. PubMed ID: 15137460
    [Abstract] [Full Text] [Related]

  • 12. Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats.
    Shigemura N, Sawa Y, Mizuno S, Ono M, Ohta M, Nakamura T, Kaneda Y, Matsuda H.
    Circulation; 2005 Mar 22; 111(11):1407-14. PubMed ID: 15781752
    [Abstract] [Full Text] [Related]

  • 13. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M, Matsushita Y, Horikawa M, Higashi K, Tomigahara Y, Kaneko H, Shirasaki F, Fujimoto M, Takehara K, Sato S.
    Arthritis Rheum; 2009 Nov 22; 60(11):3465-75. PubMed ID: 19877032
    [Abstract] [Full Text] [Related]

  • 14. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T, Kähäri VM, Black C, Vuorio E.
    J Rheumatol; 1991 Feb 22; 18(2):247-51. PubMed ID: 2023219
    [Abstract] [Full Text] [Related]

  • 15. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A, Yanaba K, Yoshizaki A, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S.
    Arthritis Rheum; 2010 Aug 22; 62(8):2476-87. PubMed ID: 20506342
    [Abstract] [Full Text] [Related]

  • 16. Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan).
    Nakanishi K, Uenoyama M, Tomita N, Morishita R, Kaneda Y, Ogihara T, Matsumoto K, Nakamura T, Maruta A, Matsuyama S, Kawai T, Aurues T, Hayashi T, Ikeda T.
    Am J Pathol; 2002 Nov 22; 161(5):1761-72. PubMed ID: 12414523
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
    Shen Y, Zhao HL, Du J, Li YT, Tan F, Huang CG, Pei G.
    Clin Exp Pharmacol Physiol; 2005 Dec 22; 32(12):1071-7. PubMed ID: 16445573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.